|
Volumn 17, Issue 1, 2007, Pages 33-36
|
Ten years results of bucillamine in the treatment of rheumatoid arthritis
|
Author keywords
10 year results; Bucillamine; Disease modifying antirheumatic drug (DMARD)
|
Indexed keywords
AURANOFIN;
AUROTHIOMALATE;
BUCILLAMINE;
DISEASE MODIFYING ANTIRHEUMATIC DRUG;
LOBENZARIT;
PENICILLAMINE;
ANTIRHEUMATIC AGENT;
CYSTEINE;
DRUG DERIVATIVE;
ADULT;
AGED;
ARTICLE;
BONE MARROW SUPPRESSION;
COHORT ANALYSIS;
CONTROLLED STUDY;
DISEASE DURATION;
DISEASE SEVERITY;
DRUG ERUPTION;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
ERYTHROCYTE SEDIMENTATION RATE;
FEMALE;
GASTROINTESTINAL DISEASE;
GRIP STRENGTH;
HUMAN;
JOINT FUNCTION;
KIDNEY DYSFUNCTION;
MAJOR CLINICAL STUDY;
MALE;
MORNING STIFFNESS;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEINURIA;
PRURITUS;
REMISSION;
RESPIRATORY TRACT DISEASE;
RHEUMATOID ARTHRITIS;
SCORING SYSTEM;
FOLLOW UP;
HOSPITALIZATION;
MIDDLE AGED;
PATIENT;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
COHORT STUDIES;
CYSTEINE;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
MIDDLE AGED;
PATIENT DROPOUTS;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
EID: 34247610962
PISSN: 14397595
EISSN: 14397609
Source Type: Journal
DOI: 10.1007/s10165-006-0533-z Document Type: Article |
Times cited : (8)
|
References (8)
|